BIO.News Newsletter

Getting this email for the first time? Welcome! We’ve expanded Good Day BIO’s distribution to all BIO members. We value your participation and want to ensure you’ve got the latest information on activities in the biotech space during this critically important time. We welcome your questions and feedback. Today, we’ve got about 860 words (4 minutes) on what happened during BIO’s virtual coronavirus summit and an example of a small biotech at the intersection of agriculture and health working on…

It's Wednesday – Day 2 of BIO’s COVID-19 virtual summit. The event kicked off yesterday, featuring biotech innovators, leading academics and government agencies on the frontlines of the rapidly evolving coronavirus public health crisis. Roughly 45 BIO members working on treatments, diagnostics and vaccines joined government officials including Ambassador Deborah Birx and Dr. Robert Kadlec for a robust discussion about the most effective approaches to respond to pandemics.In other news, we take…

We know you’ve heard it many times by now, but in case you need a reminder: even young people are being hospitalized with COVID-19. So, just stay inside, cook some fresh, healthy vegetables, and keep on Zooming. Today, we’re taking a look at another, equally urgent health threat—superbugs—as well as how ethanol plants are helping to meet the demand for hand sanitizer, in around 780 words, just under 4 minutes.

It’s Monday. We hope you were able to find a little enjoyment and peace over the weekend. Today, we have the perfect thing for your solitary walks in the park: a new episode of the I AM BIO Podcast, taking a look at Regeneron's innovative work to treat COVID-19 symptoms. And as discussions continue on the Hill about the coronavirus bailout package, we have some thoughts about the role of Sustainable Aviation Fuels and the intersection of the economy, climate change, and public health.Here are…

It’s Friday. Check out what we’re doing to help the industry collaborate and find COVID-19 cures as quickly as possible, as well as a new law in Maine that will support the biobased economy. Here are 825 words, around 4 minutes.

Here’s an important reminder as we head into Thursday: While we know older adults and people with underlying illnesses face the highest risk of complications and death from COVID-19, new numbers show younger adults are getting seriously ill, too. So, no matter your age or how you feel today, it’s important to keep up the social distancing, for others and for yourself. We’re all in this together.  Today, we’re looking at more coronavirus news, including the role of air quality and low-carbon…

In these unprecedented times, America’s biopharmaceutical companies are coming together to achieve one shared goal: the eradication of COVID-19. BIO and PhRMA have teamed up to declare a shared set of principles to guide our industry during this crisis as we work together toward vaccines and cures, including: Rapidly screen our vast global libraries of medicines, dedicate top scientists, and use our investments in new technologies to identify potential treatments and speed up the development…

After a Monday that felt like it was three weeks long, we’ve got some good news: the first COVID-19 vaccine trial started yesterday, and consumers like gene-edited foods once they have information about them. Here are 825 words, about 4 minutes. P.S. Happy St. Patrick’s Day. FYI: Beer and whiskey, Irish or not, taste almost as good at home as they do in a crowded bar—and they’re cheaper.

As we start what could be a critically important week in the COVID-19 pandemic, we have a special request: tell us what you’re doing to respond. We want to know what you’re doing about business continuity, especially lab and manufacturing activities, travel and events, worker safety, teleworking, supply chains, the works. We'll compile the plans (with your private details scrubbed) and share them in our coronavirus resource center.   Send your plans and any questions to covidresponse@bio.org. …

It’s Friday the 13th. The House continues to work with the White House on a coronavirus package, while the Senate has canceled next week’s scheduled recess. In the meantime, we’re looking at SEC regulatory changes that will help small public biotech companies, as well as a Senate Ag hearing yesterday with some strong messages about the need for a transparent, science-based regulatory process, in 760 words, about 3 minutes, 45 seconds.